You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anthracycline chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participants Undergoing Anthracycline Chemo Trial in Cincinnati (autoRIC®)

Recruiting
  • Participants Undergoing Anthracycline Chemotherapy
  • autoRIC®
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Jun 24, 2022

Cancer Survivor With History of Anthracycline Chemo Trial in Manhattan (Beetroot juice, Black currant juice)

Completed
  • Cancer Survivor With History of Anthracycline Chemotherapy
  • Beetroot juice
  • Black currant juice
  • Manhattan, Kansas
    Kansas State University - Clinical Integrative Physiology Labora
Mar 30, 2022

Heart Failure Trial in Ottawa (L-carnitine)

Terminated
  • Heart Failure
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Aug 12, 2022

Breast Cancer Female Trial in Edmonton (50% caloric restriction, Aerobic exercise)

Recruiting
  • Breast Cancer Female
  • 50% caloric restriction
  • Aerobic exercise
  • Edmonton, Alberta, Canada
    University of Alberta
Jul 11, 2022

Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)

Not yet recruiting
  • Endometrial Carcinoma
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • São Paulo, Brazil
    Instituto do Coração
Aug 16, 2023

Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)

Withdrawn
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 19, 2021

Anthracycline-based Chemotherapy on Peripheral Vascular Function

Completed
  • Breast Cancer
  • +2 more
  • Arterial blood pressure
  • +3 more
  • Manhattan, Kansas
    Lafene Health Center
Mar 30, 2022

Soft Tissue Sarcoma Adult Trial (Surufatinib)

Not yet recruiting
  • Soft Tissue Sarcoma Adult
  • (no location specified)
Oct 29, 2023

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

Completed
Has Results
  • Breast Neoplasms
  • Breast Cancer
  • Houston, Texas
  • +2 more
Jan 19, 2023

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

Breast Cancer Trial (non invasive auricular vagal stimulation, usual medical treatment, sham stimulation)

Not yet recruiting
  • Breast Cancer
  • non invasive auricular vagal stimulation
  • +2 more
  • (no location specified)
May 17, 2022

Checkpoint Inhibitors in Triple Negative Breast

Recruiting
  • Triple Negative Breast Cancer
  • Whole Genome Sequencing
  • +7 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Jun 20, 2023

Cardiomyopathies, Chemo Effect, Diastolic Dysfunction Trial in Tehran (Bisoprolol, Placebo)

Completed
  • Cardiomyopathies
  • +3 more
  • Tehran, Iran, Islamic Republic of
    Rasool Akram hospital
Dec 30, 2021

Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

Recruiting
  • Luminal B/HER2-negative Breast Cancer
  • Dalpiciclib combined with aromatase inhibitors
  • anthracycline-cyclophosphamide followed by taxane
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022

Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)

Recruiting
  • Breast Cancer
  • Non Hodgkin Lymphoma
  • Middlesbrough, Teesside, United Kingdom
    South Tees Hospitals NHS FT
Oct 20, 2022

Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

Completed
  • Breast Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Cancer, Heart Failure, Cardiotoxicity Trial in Toronto (Atorvastatin, Placebo oral tablet)

Active, not recruiting
  • Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital
Feb 4, 2022

Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

Completed
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Survey
  • Rochester, New York
    University of Rochester Medical Center
Mar 4, 2021

Breast Cancer Trial in Frankfurt (MEDI4736 (Anti PD-L1), Placebo, nab-Paclitaxel)

Completed
  • Breast Cancer
  • MEDI4736 (Anti PD-L1)
  • +4 more
  • Frankfurt, Hessen, Germany
    Centrum für Hämatologie und Onkologie am Bethanien-Krankenhaus
Feb 11, 2021

Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant , Tropisetron and Olanzapine
  • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
  • Henan, Henan, China
  • +1 more
Apr 11, 2022

Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Recruiting
  • Breast Neoplasms
  • Taxanes or/and anthracycline-based therapy
  • Shengyang, Liaoning, China
  • +1 more
Jan 19, 2022